Advertisement

Topics

"Avista Pharma Solutions, Inc.∨derfield=date∨derval=DESC" News Stories

10:48 EDT 16th July 2019 | BioPortfolio

Here are the most relevant search results for "Avista Pharma Solutions, Inc.∨derfield=date∨derval=DESC" found in our extensive news archives from over 250 global news sources.

More Information about Avista Pharma Solutions, Inc.∨derfield=date∨derval=DESC on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Avista Pharma Solutions, Inc.∨derfield=date∨derval=DESC for you to read. Along with our medical data and news we also list Avista Pharma Solutions, Inc.∨derfield=date∨derval=DESC Clinical Trials, which are updated daily. BioPortfolio also has a large database of Avista Pharma Solutions, Inc.∨derfield=date∨derval=DESC Companies for you to search.

Showing "Avista Pharma Solutions derfield date derval DESC" News Articles 1–25 of 17,000+

Tuesday 16th July 2019

Top 5 Vendors in the Global Genitourinary Drugs Market 2019-2023 | Technavio

The high prevalence of genitourinary diseases is one of the critical reasons that will drive genitourinary drugs market growth. Bacterial infections or STDs can cause genitourinary disorders. It also includes various carcinomas such as ovarian cancer, cervical cancer, bladder cancer, and prostate cancer. Age-related ailments such as Alzheimer’s and disorders like diabetes, obesity, and multiple...


NCI Announces Appointment of Charles Hicks as Chief Financial Officer

NCI Information Systems, Inc. (NCI), a leading provider of advanced information technology solutions and professional services to U.S. federal government agencies, today announced Charles (Chuck) Hicks Jr. has joined the company as executive vice president, chief financial officer and treasurer. Hicks brings more than 25 years of industry experience to his role at NCI leading the finance functi...

Contagion® Adds MAD-ID® to Its Strategic Alliance Partnership Program

Contagion®, the nation’s leading multimedia resource dedicated to providing up-to-date, disease-specific information to health care practitioners and specialists in the field of infectious diseases, announces the addition of Making A Difference in Infectious Diseases (MAD-ID®) to its Strategic Alliance Partnership (SAP) program. “We are very excited to be partnering with the MAD-ID® org...


STAT Plus: Pharmalittle: Pharma keeps winning in Washington; J&J faces test as Oklahoma opioid trial wraps up

Lawyers for Oklahoma urged a judge to find Johnson & Johnson culpable for the state opioid crisis and pay $17.5 billion to help clean up the damage.

MTI America Welcomes Marc Pyatt as New Physical Medicine National Product Leader

MTI America announces that Marc Pyatt has joined the company as the Physical Medicine National Product Leader. Pyatt brings more than two decades of experience as a physical therapist, manager and senior clinical specialist, for some of the nation’s leading workers’ compensation firms. In his role at MTI America, he’ll work closely with the company’s director of physical medicine, Jef...

#news #biotech Sosei Heptares pens $1B biobucks GPCR pact with Genentech

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Sosei Heptares pens $1B biobucks GPCR pact with Genentech .After spinning out two companies at the start of the year, Sosei Heptares has now inked a new deal … Continue reading →

Pharma industry M&A deals in Q2 2019 total $114.8bn globally

Total pharma industry M&A deals in Q2 2019 worth $114.8bn were announced globally, according to GlobalData’s deals database. Embed this...Read More... The post Pharma industry M&A deals in Q2 2019 total $114.8bn globally appeared first on Pharmaceutical Technology.

Empyrean Partners with SAVVI Financial to Engage and Empower Employees by Connecting Financial Guidance with Benefit Decisions

Empyrean Benefit Solutions, Inc., the Hi-Touch Benefits Administration company, announced a strategic partnership with SAVVI Financial LLC, a leading technology-enabled financial wellness platform, to provide personalized, analytics-driven financial planning and management resources. SAVVI is fully integrated within Empyrean’s benefits enrollment and administrative platform, which serves more...

Sigrid Therapeutics announces that all patients have completed treatment with SiPore15 in the STAR Trial

First-in-Class MSP (mesoporous silica particle) based therapy targets blood sugar and other metabolic risk factors. Stockholm, Sweden, July 16, 2019 – Sigrid Therapeutics AB, a biotechnology company developing a new class of therapies for metabolic diseases and disorders, today announces that all patients have completed treatment with SiPore15 in the STAR trial. Development is well on...

Pharma industry venture financing deals in Q2 2019 total $2.72bn in US

Total pharma industry venture financing deals in Q2 2019 worth $2.72bn were announced in the US, according to GlobalData’s deals...Read More... The post Pharma industry venture financing deals in Q2 2019 total $2.72bn in US appeared first on Pharmaceutical Technology.

Pharma industry deals in Q2 2019 total $121.51bn globally

Total pharma industry deals for Q2 2019 worth $121.51bn were announced globally, according to GlobalData’s deals database. Embed this chart...Read More... The post Pharma industry deals in Q2 2019 total $121.51bn globally appeared first on Pharmaceutical Technology.

Reliance eHealth Collaborative Goes Live on Virtual Health Record from IMAT Solutions

IMAT’s Health Data Platform also serves as foundation for all HIE initiatives. OREM, Utah (PRWEB) July 16, 2019 IMAT Solutions, a leader in delivering innovative, real-time, healthcare data management and population health reporting solutions, announced that Reliance eHealth Collaborative, a growing health information exchange (HIE) in the Pacific Northwest, is leveraging IMAT’s comprehensive...

Pharma industry private equity deals in Q2 2019 total $2.98bn globally

Total pharma industry private equity deals in Q2 2019 worth $2.98bn were announced globally, according to GlobalData’s deals database. Embed...Read More... The post Pharma industry private equity deals in Q2 2019 total $2.98bn globally appeared first on Pharmaceutical Technology.

Optimal Just-in-Time Service Changing the Paradigm of Cancer Trials

First-patient-in milestone achieved in only two weeks with Cancer Treatment Centers of America Optimal Just-in-Time, a service of PPD’s Accelerated Enrollment

How Quality by Design Changes Your Drug Product from Concept to Commercial, Upcoming Webinar Hosted by Xtalks

In this free webinar, the featured speaker will demonstrate how the Quality by Design cascade ensures this expectation is not only met but is clearly articulated in specific terms. This presentation will include an in-depth overview of all four stages of the Quality by Design process. TORONTO (PRWEB) July 16, 2019 Brilliant science is required to identify potential therapeutics. The skills needed...

New Partnership With RF IDeas Brings Seamless Authentication to ForgeRock® Users

RF IDeas, Inc. and ForgeRock® have announced the availability of seamless authentication solutions, consolidating all secure services into a single user profile with no passwords required. RF IDeas is a leading innovator and manufacturer of employee credential readers for logical access applications such as computer and network access, identification, secure pull print, and time and attendance...

Lonza Selects Rockwell Automation for Digital Transformation of Pharmaceutical Operations

Lonza to use PharmaSuite MES software, along with FactoryTalk InnovationSuite to accelerate paperless, 24/7 production of cutting-edge capsules Lonza has selected Rockwell Automation for the turnkey implementation of the Lonza strategic vision of bringing the digital factory to nine former Capsugel facilities that manufacture drug capsules. The Switzerland-based company, founded in 1897 with app...

InSync Healthcare Solutions Releases Updates to Its Cloud-Based Offerings For OB/GYN Specialty Practices

Updates include electronic access to the obstetric patient record for antepartum and postpartum patient charts InSync Healthcare Solutions, a leading provider of cloud-based, fully-integrated healthcare solutions, announced today the availability of extensive updates to its full-suite of cloud-based offerings for the obstetrics and gynecology (OB/GYN) specialty. The recently released updates ...

VetStem Biopharma Shares the Success Story of Seve who was Treated with VetStem Cell Therapy by Dr. Cindy Echevarria

Seve, a Golden Retriever, was treated for severe osteoarthritis in his hips with VetStem Regenerative Cell Therapy by Dr. Cindy Echevarria of VCA University Animal Hospital in Dallas. POWAY, Calif. (PRWEB) July 16, 2019 At nearly eleven years old, Seve, a white Golden Retriever, began showing symptoms of discomfort in his back legs. According to his owner, in the last year or so, he was a little...

Redox Launches Effort with Advanced Technology Development Center to Help Health Technology Startups Scale their Businesses

Startups of ATDC’s HealthTech Program gain access to Redox’s full-service integration platform to help get products to market quickly Advanced Technology Development Center (ATDC), Georgia’s technology incubator, announced a new collaboration with Redox that offers access to Redox’s full-service integration platform to startups in ATDC’s Health Technolo

LivaNova Combats Leg Ischemia with Breakthrough Bidirectional Cannula

CE Marked Bi-Flow is the only cannula designed to prevent leg ischemia during cardiac procedures requiring femoral artery cannulation LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today launched its innovative arterial femoral cannula, Bi-Flow, designed to prevent limb ischemia during cardiac surgery. LivaNova Bi-Flow received CE Mark earlier this year and is the on...

Catalent Biologics Announces Agreement to Provide Additional Production of Approved Gene Therapy Treatment for Spinal Muscular Atrophy

Catalent Biologics today announced a long-term strategic agreement for the development and manufacturing of Zolgensma® (onasemnogene abeparvovec-xioi), an AveXis gene therapy treatment for spinal muscular atrophy (SMA). SOMERSET, N.J. (PRWEB) July 16, 2019 Catalent Biologics today announced a long-term strategic agreement for the development and manufacturing of Zolgensma® (onasemnogene...

Pharma industry venture financing deals in Q2 2019 total $3.72bn globally

Total pharma industry venture financing deals in Q2 2019 worth $3.72bn were announced globally, according to GlobalData’s deals database. Embed...Read More... The post Pharma industry venture financing deals in Q2 2019 total $3.72bn globally appeared first on Pharmaceutical Technology.

Pharma industry M&A deals in Q2 2019 total $19.5bn in US

Total pharma industry M&A deals in Q2 2019 worth $19.5bn were announced in the US, according to GlobalData’s deals database....Read More... The post Pharma industry M&A deals in Q2 2019 total $19.5bn in US appeared first on Pharmaceutical Technology.

Deep reporting here from @NicholasFlorko and @levfacher on how pharma, under fire from everyone in Washington for drug prices, keeps winning policy battles https://www.statnews.com/2019/07/16/pharma-still-winning/ … via @statnewspic.twitter.com/WWRUeM

Deep reporting here from @NicholasFlorko and @levfacher on how pharma, under fire from everyone in Washington for drug prices, keeps winning policy battles https://www.statnews.com/2019/07/16/pharma-still-winning/ … via @statnews pic.twitter.com/WWRUeMBqoR


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks